Lemongrass Antimicrobial Effects and Oral Health

This is lemongrass's strongest laboratory suit and its weakest clinical one, and the distance between those two facts is where almost every exaggerated claim about the plant comes from. In a petri dish, lemongrass essential oil is genuinely impressive: it inhibits a broad range of bacteria including Staphylococcus aureus and Escherichia coli, it disrupts biofilms, and it is one of the more reliably active essential oils against Candida yeasts. Those results have been reproduced by many independent groups. They are not controversial.

What they are, however, is in vitro. Almost the entire antimicrobial literature on this plant consists of the oil applied directly to organisms in a well, on a plate, or in a vapour chamber — at concentrations that are trivial to create in glassware and impossible to create safely inside a human body. The handful of human studies that exist are small, and all of them are topical: an oral rinse for thrush, a mouthwash, a scalp tonic. Not one is a study of swallowing lemongrass to fight an infection, and there is no established safe oral dose of the oil. This page separates the two carefully, gives the in-vitro work its due, and then says plainly what it does and does not license.


Table of Contents

  1. Once More: This Is the Oil, Not the Tea
  2. The In-Vitro Antibacterial Record
  3. Reading a Minimum Inhibitory Concentration Without Being Fooled
  4. Candida and the Antifungal Data
  5. Biofilms and Why They Matter
  6. Oral Thrush: The Gentian Violet Comparison Trial
  7. Mouthwash, Plaque and Gingivitis
  8. Halitosis and the Deodorant Effect
  9. Dandruff and the Species Confusion
  10. Food Preservation and Household Use
  11. Why This Is Not an Antibiotic
  12. How to Use It Safely
  13. Safety and Cautions
  14. Key Research Papers
  15. Connections
  16. Featured Videos

Once More: This Is the Oil, Not the Tea

Every antimicrobial number quoted on this page comes from lemongrass essential oil or from purified citral — not from a cup of lemongrass tea. The distinction is not pedantry:

So the correct reading of "lemongrass kills methicillin-resistant Staphylococcus aureus (MRSA) in the lab" is: a concentrated distillate, applied directly to bacteria growing on a plate, at a concentration achieved in glassware, inhibited their growth. That is a legitimate and interesting result. It is not a reason to drink anything, and it is not a reason to skip an antibiotic.

Back to Table of Contents

The In-Vitro Antibacterial Record

Evidence tier: preliminary (in vitro). The antibacterial literature on lemongrass oil is large and consistent. Representative work includes Antibacterial activity of lemongrass (Cymbopogon citratus) oil against some selected pathogenic bacteria by Naik, Fomda, Jaykumar and Bhat in the Asian Pacific Journal of Tropical Medicine in 2010, which screened the oil against a panel of clinical isolates, and Lemon grass (Cymbopogon citratus) essential oil as a potent anti-inflammatory and antifungal drug by Boukhatem, Ferhat, Kameli, Saidi and Kebir in the Libyan Journal of Medicine in 2014.

Across this literature, the pattern is:

None of this has been translated into a systemic human antibacterial treatment, and the membrane mechanism is a large part of why: a compound that dissolves microbial membranes at a given concentration is not selective enough to circulate in blood at that concentration.

Back to Table of Contents

Reading a Minimum Inhibitory Concentration Without Being Fooled

The single most useful skill for reading this literature is knowing what a minimum inhibitory concentration (MIC) means and what it does not.

A minimum inhibitory concentration is the lowest concentration of a substance that prevents visible growth of an organism under specific laboratory conditions. It is a property of the substance and the assay — the medium, the inoculum size, whether an emulsifier was used, whether growth was read at 24 or 48 hours. Essential-oil MICs vary widely between papers for exactly these reasons, which is why an article quoting one number as if it were a physical constant deserves suspicion.

Then ask the question that dissolves most exaggerated claims: could a human body ever reach this concentration at the site of infection?

Two further reality checks. In-vitro tests use clean, planktonic bacteria in nutrient broth — not organisms embedded in pus, biofilm, necrotic tissue or a protein-rich exudate, all of which bind and inactivate lipophilic compounds. And in-vitro tests have no immune system either helping or being harmed. The gap between a plate and a patient is not a technicality; it is where the great majority of promising antimicrobials die.

Back to Table of Contents

Candida and the Antifungal Data

Evidence tier: preliminary (in vitro). The antifungal data are, if anything, more consistent than the antibacterial data. Antifungal activity of the lemongrass oil and citral against Candida spp. by Silva, Guterres, Weisheimer and Schapoval in the Brazilian Journal of Infectious Diseases in 2008 tested both the whole oil and isolated citral against multiple Candida species and found activity in both, indicating that citral carries much of the effect. Tyagi and Malik reported liquid- and vapour-phase antifungal activity of Cymbopogon citratus oil against Candida albicans in BMC Complementary and Alternative Medicine in 2010, with microscopy showing gross damage to the fungal cell envelope. Boukhatem's 2014 paper reached similar conclusions.

Fungal cells, like bacterial cells, have membranes that monoterpenes partition into; the mechanism is the same physical disruption, sometimes with additional effects on ergosterol-containing membranes and on the yeast-to-hyphal transition that Candida uses to invade tissue.

What this supports: interest in lemongrass oil for surface and mucosal antifungal applications, which is exactly where the one human study went.

What it does not support: treating any invasive or systemic fungal infection, treating vaginal candidiasis with undiluted oil (a route that causes chemical burns), or the ill-defined internet construct of "systemic candida overgrowth."

Back to Table of Contents

Biofilms and Why They Matter

Evidence tier: preliminary (in vitro). A biofilm is a community of microbes embedded in a self-produced matrix, stuck to a surface. Dental plaque is a biofilm; so is the slime on a catheter, and much of chronic wound and sinus infection. Biofilm organisms can be tens to hundreds of times harder to kill than the same species floating free, which is why biofilm-active agents attract attention.

Lemongrass oil and citral have been reported to reduce biofilm formation and to disrupt established biofilms in several in-vitro models, including the dental caries organism Streptococcus mutans. The plausible reason is again mechanical rather than clever: a membrane-disrupting terpene does not care whether a cell is in a biofilm, and the oil's lipophilicity may help it penetrate the matrix where water-soluble antiseptics struggle.

This is genuinely the most interesting frontier for lemongrass, and it is also where the hype gets furthest ahead of the evidence. Anti-biofilm activity on a polystyrene plate is not clinical efficacy against dental plaque in a mouth, where saliva dilutes everything, the biofilm regrows within hours, and mechanical removal by a toothbrush remains the dominant intervention. PubMed topic search: Cymbopogon citratus, citral and biofilm inhibition.

Back to Table of Contents

Oral Thrush: The Gentian Violet Comparison Trial

Evidence tier: preliminary human. The study is Treatment of oral thrush in human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet, by Wright, Maree and Sibanyoni, published in Phytomedicine in 2009. It was conducted in a South African hospice that, for financial reasons, routinely treated thrush with lemon juice or a lemongrass infusion grown on site, and it compared these inexpensive, locally available topical treatments for oral candidiasis in people with human immunodeficiency virus/acquired immunodeficiency syndrome.

The design randomised 90 HIV-positive patients with oral thrush to lemon juice, lemongrass infusion or gentian violet 0.5% (the first-line oral-thrush medicine in South Africa, disliked by patients because its purple stain marks them as HIV-positive) for 11 days; 83 completed the study. In the intention-to-treat analysis, which counts every patient as randomised, none of the differences was statistically significant. Among the patients who completed the trial, lemon juice (p < 0.02) and lemongrass (p < 0.05) did better than gentian violet. Read in context, this is a pragmatic, resource-appropriate study asking a real question: does a cheap local option work as well as the standard topical medicine?

Its limits are substantial:

What it does contribute is important: it is one of the few human studies of lemongrass against an actual infection. A 2024 scoping review found 8 clinical studies of lemongrass essential oil published between 2013 and 2022, including studies in gum disease and in pityriasis versicolor, a fungal skin infection. A 2024 systematic review of 10 laboratory and clinical studies of lemongrass (Cymbopogon citratus) against oral thrush found strong antifungal effects but limited scientific evidence in people, and called for clinical trials.

Back to Table of Contents

Mouthwash, Plaque and Gingivitis

Evidence tier: preliminary human (small clinical study). The dental literature contains a three-arm study of a 0.25% lemongrass oil mouthwash compared with chlorhexidine and a control, reported in the Journal of Clinical and Diagnostic Research in 2015 (Dany and colleagues), with plaque and gingival indices as endpoints. In this double-blind trial, 60 people had a professional cleaning and were then randomised to 0.25% lemongrass oil mouthwash, 0.2% chlorhexidine mouthwash, or the cleaning alone, rinsing twice daily for 21 days. The lemongrass group had the largest fall in plaque and gingival index scores at days 14 and 21. Small studies of this shape are a staple of the dental-materials literature and they are useful as a first pass, with familiar caveats: short duration, small samples, single centre, and outcome indices that are examiner-scored.

The relevant background is that chlorhexidine is the benchmark antiseptic mouthwash and a demanding comparator — it substantively reduces plaque and gingivitis, and its problems are tolerability rather than efficacy (tooth staining, taste disturbance, calculus). Any plant-oil rinse is being measured against a high bar, and essential-oil mouthwashes as a class do have real supporting evidence — the long-established thymol/eucalyptol/menthol/methyl-salicylate formulation is the best-studied example. Lemongrass is a plausible member of that class with a fraction of the data. A 2024 scoping review of 8 clinical studies reported lemongrass essential oil performing similarly to chlorhexidine against gingivitis and similarly to the antibiotic doxycycline in periodontitis, plus small studies in oral malodour, pityriasis versicolor and dandruff; the authors stress that its effectiveness, safety, drug interactions and long-term tolerability still need research.

Honest bottom line for gingivitis and plaque: a lemongrass-oil rinse is an adjunct with preliminary support, not a substitute for brushing, flossing or professional cleaning. Nothing in a bottle removes plaque as well as mechanical disruption does, and periodontitis is treated by dental professionals; a rinse is not the whole treatment.

Also — and this matters — a mouthwash is swished and spat, not swallowed, and the studied strength was 0.25%: one four-hundredth of the strength of neat oil. Stronger home-made rinses have not been studied, and that dilution is the point.

Back to Table of Contents

Halitosis and the Deodorant Effect

Evidence tier: preliminary, largely mechanistic. Most persistent bad breath originates in the mouth, from anaerobic bacteria on the tongue and in periodontal pockets producing volatile sulphur compounds. Two things could in principle help: reducing the bacteria, and masking or chemically neutralising the odour.

Lemongrass oil is plausibly capable of both — it has in-vitro activity against oral anaerobes, and it is a strong, clean-smelling aromatic. But the second effect is cosmetic and short-lived, and the first has not been demonstrated clinically for halitosis. Masking is worth knowing about precisely because it is so easy to mistake for treatment: if a rinse makes your breath smell of lemon for twenty minutes, that is not evidence that the underlying cause changed.

The interventions with actual evidence for halitosis are tongue cleaning, treating gum disease, treating dental decay, and managing dry mouth. Bad breath that persists despite good oral hygiene usually has one of those causes in the mouth, which a stronger mouthwash does not remove. See also Oil Pulling for a related practice with similarly thin evidence.

Back to Table of Contents

Dandruff and the Species Confusion

Evidence tier: preliminary human (controlled). The study is Anti-dandruff hair tonic containing lemongrass (Cymbopogon flexuosus) oil, by Chaisripipat, Lourith and Kanlayavattanakul in Forschende Komplementärmedizin (now Complementary Medicine Research) in 2015. In this randomised, double-blind, placebo-controlled split-head study of 30 volunteers, hair tonics with 5%, 10% and 15% lemongrass oil applied twice daily reduced dandruff by 52%, 81% and 74% at day 14.

Note the binomial carefully, because most articles that cite this study get it wrong: the oil tested was from Cymbopogon flexuosus, East Indian lemongrass, not the culinary Cymbopogon citratus that you cook with and brew. The two species are close relatives with overlapping but not identical oil profiles. That is a real limitation on transferring the result, and it is the same genus-level sloppiness that produces the claim that lemongrass repels mosquitoes as citronella does — citronella oil comes mainly from C. nardus and C. winterianus.

Mechanistically the dandruff result is coherent: seborrhoeic dermatitis and dandruff involve Malassezia yeasts, lemongrass oil has antifungal activity, and a scalp is a surface where you can apply a real concentration. It is also a plausible-but-preliminary finding from a single small study, competing against well-established medicated shampoos (ketoconazole, ciclopirox, zinc pyrithione, selenium sulphide) that have far more evidence.

Back to Table of Contents

Food Preservation and Household Use

Evidence tier: preliminary (in vitro and food-model). The most practically defensible application of lemongrass oil's antimicrobial activity is not in a person at all — it is in food and around the house, where the concentration is under your control and no absorption question arises.

Back to Table of Contents

Why This Is Not an Antibiotic

It is worth being blunt, because this claim area causes real harm when misread.

  1. No systemic evidence exists. There is no human study of lemongrass, in any form, treating a bacterial infection anywhere other than the mouth's surface. Zero.
  2. The mechanism is non-selective. Membrane disruption at antimicrobial concentrations damages human cells too. This is why membrane-active agents make good antiseptics and bad systemic drugs.
  3. Delay is the danger. Bacterial pneumonia, cellulitis, pyelonephritis, sepsis and dental abscess all get worse on the timescale of hours to days. Treating them with a plant oil while an infection advances is how a treatable illness becomes a hospital admission.
  4. "Antibiotic resistance" is not a reason to substitute. Resistance is a genuine crisis and it is an argument for prescribing antibiotics correctly, not for replacing them with untested alternatives. Essential oils are being studied as adjuncts and as surface antimicrobials for good reasons; none of that research proposes them as systemic replacements.
  5. Injecting, instilling or douching with essential oil causes chemical injury. No medical use of these routes exists.

What lemongrass oil legitimately is: a broad-spectrum topical and environmental antimicrobial with a real laboratory record, a small amount of supportive human data for mucosal and skin surfaces, and a place in food preservation research.

Back to Table of Contents

How to Use It Safely

Mouth rinse

The studied strength was 0.25% — a very dilute preparation. Commercially formulated products handle emulsification properly; oil and water do not mix, and a drop of neat oil floating on water delivers a concentrated hit to whatever mucosa it touches. In the studies the rinse was swished and spat out; there is no established safe oral dose of the oil. Burning, ulceration or taste disturbance are signs of irritation. A rinse is an adjunct to brushing and flossing, not a replacement, and not a treatment for a dental abscess, which dentists treat, usually with an antibiotic.

Skin and scalp

Aromatherapy practice dilutes it in a carrier oil, conventionally to about 1–2% for general use, with a 24–48 hour patch test on a small area first. Lemongrass oil is a documented irritant and contact allergen. Broken skin, mucous membranes and the eye area are the most easily injured. Essential oils are a recognised cause of poisoning in young children, and there are no safety data for use on infants.

Household and food

Formulated repellents and cleaners carry their own directions. Culinary lemongrass used in cooking for its flavour and mild preservative effect is ordinary food use.

Uses With No Safety Basis

Back to Table of Contents

Safety and Cautions

Skin. The dermatology reference is de Groot and Schmidt, Essential oils, part V: peppermint oil, lavender oil, and lemongrass oil, Dermatitis, 2016, which documents irritation and allergic contact dermatitis from lemongrass oil. Sensitisation is cumulative — someone who has used an oil for years without trouble can still become allergic to it.

Ingestion. There is no established safe oral dose of lemongrass essential oil and no reason to look for one. Concentrated essential oils cause mucosal injury and, in children, are a recognised cause of poisoning. The tea is a different matter and has a good safety record (see the Leite 1986 human trial, which found no toxicity from the infusion).

Pregnancy and breastfeeding. Lemongrass is traditionally treated as an emmenagogue. Culinary amounts are generally considered fine; there is no pregnancy safety data for the essential oil, strong daily medicinal teas or concentrated preparations, which carry that emmenagogue reputation at a concentrated dose. There are no safety data for essential oils used on or near infants.

High-dose citral. Animal work has reported prostatic hyperplasia in rats from repeated high-dose citral, attributed to an estrogen-like action — another argument against ingesting concentrated citral.

Children and pets. Concentrated essential oils are hazardous to small children if swallowed and can irritate airways. Cats in particular metabolise terpenes poorly. Bottles stored out of reach and ventilated rooms reduce these exposures.

Disclaimer. This page is educational and is not medical advice. The antimicrobial evidence for lemongrass is overwhelmingly in vitro; it does not establish that lemongrass treats any infection in a human body. Lemongrass is not an antibiotic or antifungal drug and has not been tested as a replacement for one. Fever, spreading redness, swelling, severe pain, difficulty breathing or swallowing, or a rapidly worsening illness are signs of infection that hospitals treat as urgent. There is no established safe oral dose of lemongrass essential oil.

Back to Table of Contents

Key Research Papers

Most citations link to their PubMed record or DOI; the topic searches resolve to the literature as indexed today. Evidence tier is stated for each — note how many read "in vitro."

  1. Preliminary (in vitro). Naik MI, Fomda BA, Jaykumar E, Bhat JA. Antibacterial activity of lemongrass (Cymbopogon citratus) oil against some selected pathogenic bacteria. Asian Pacific Journal of Tropical Medicine, 2010;3(7):535-538. doi:10.1016/S1995-7645(10)60129-0
  2. Preliminary (in vitro). Silva CB, Guterres SS, Weisheimer V, Schapoval EE. Antifungal activity of the lemongrass oil and citral against Candida spp. Brazilian Journal of Infectious Diseases, 2008;12(1):63-6 — tested the whole oil and isolated citral side by side. PubMed PMID: 18553017
  3. Preliminary (in vitro). Tyagi AK, Malik A. Liquid and vapour-phase antifungal activities of selected essential oils against Candida albicans: microscopic observations and chemical characterization of Cymbopogon citratus. BMC Complementary and Alternative Medicine, 2010;10:65. PubMed PMID: 21067604
  4. Preliminary (in vitro). Boukhatem MN, Ferhat MA, Kameli A, Saidi F, Kebir HT. Lemon grass (Cymbopogon citratus) essential oil as a potent anti-inflammatory and antifungal drug. Libyan Journal of Medicine, 2014;9:25431. PubMed PMID: 25242268
  5. Preliminary (in vitro, resistant organisms). Warnke PH, Becker ST, Podschun R, et al. The battle against multi-resistant strains: renaissance of antimicrobial essential oils as a promising force to fight hospital-acquired infections. Journal of Cranio-Maxillofacial Surgery, 2009;37(7):392-7 — lemongrass among the more active oils screened against resistant isolates. PubMed PMID: 19473851
  6. Preliminary human (topical, oral candidiasis). Wright SC, Maree JE, Sibanyoni M. Treatment of oral thrush in HIV/AIDS patients with lemon juice and lemon grass (Cymbopogon citratus) and gentian violet. Phytomedicine, 2009;16(2-3):118-24 — randomised trial against gentian violet. PubMed PMID: 19109001
  7. Preliminary human (small clinical, dental). Dany SS, Mohanty P, Tangade P, Rajput P, Batra M. Efficacy of 0.25% lemongrass oil mouthwash: a three arm prospective parallel clinical study. Journal of Clinical and Diagnostic Research, 2015;9(10):ZC13-7. PubMed PMID: 26557608
  8. Preliminary human (controlled, scalp). Chaisripipat W, Lourith N, Kanlayavattanakul M. Anti-dandruff hair tonic containing lemongrass (Cymbopogon flexuosus) oil. Forschende Komplementärmedizin (now Complementary Medicine Research), 2015;22(4):226-9 — C. flexuosus, not the culinary species. PubMed PMID: 26566122
  9. Preliminary (in vitro, dental biofilm). PubMed topic search: Cymbopogon citratus, Streptococcus mutans and biofilm. — Search PubMed
  10. Preliminary (in vitro, food science). PubMed topic search: lemongrass oil in food preservation and active packaging. — Search PubMed
  11. Preliminary (animal skin, repellency). Oyedele AO, Gbolade AA, Sosan MB, Adewoyin FB, Soyelu OL, Orafidiya OO. Formulation of an effective mosquito-repellent topical product from lemongrass oil. Phytomedicine, 2002;9(3):259-62. PubMed PMID: 12046869
  12. Review (skin safety). de Groot A, Schmidt E. Essential oils, part V: peppermint oil, lavender oil, and lemongrass oil. Dermatitis, 2016;27(6):325-332. PubMed PMID: 27775966
  13. Review (clinical studies). Kusuma IY, Perdana MI, Vágvölgyi C, Csupor D, Takó M. Exploring the clinical applications of lemongrass essential oil: a scoping review. Pharmaceuticals (Basel), 2024;17(2):159. PubMed PMID: 38399374
  14. Review (oral thrush). Cuenca-León K, Lima-Illescas M, Pacheco-Quito EM, Vélez-León E, Zarzuelo-Castañeda A. Effectiveness of lemon verbena (Cymbopogon citratus) in oral candidiasis: a systematic review. Clinical, Cosmetic and Investigational Dentistry, 2024;16:295-305. PubMed PMID: 39286661
  15. Reviews (overall). Shah G, et al. Scientific basis for the therapeutic use of Cymbopogon citratus, Stapf (lemon grass). Journal of Advanced Pharmaceutical Technology & Research, 2011. Find on PubMed · Ekpenyong CE, Akpan E, Nyoh A. Ethnopharmacology, phytochemistry, and biological activities of Cymbopogon citratus (DC.) Stapf extracts. Chinese Journal of Natural Medicines, 2015. Find on PubMed
  16. Context. Essential-oil mouthwashes for plaque and gingivitis: systematic reviews · chlorhexidine, the benchmark comparator — Search PubMed

Back to Table of Contents

Back to Table of Contents

Connections

Back to Table of Contents